The biobanking of high-quality human biospecimens, such as tissue, blood, and other bodily fluids, combined with relevant patient data, provides an important scientific basis for personalized medicine. Biobanking facilitates the discovery of novel Disease Specific Biomarkers (DSB) that are particularly associated with specific illnesses, including cancer. Tumor biomarker identification is revolutionizing personalized medicine, diagnosis, enhancing prognosis and therapeutic response, thereby transforming medical care and enhancing cancer treatments. Our biobanking adopts premeditated pioneering technology enabling collection, identification, storage, quality control, transportation, and distribution of biospecimens from its extensive inventory or in response to a just-in-time request. Quality of YBL’s processed Biospecimens meet International standards